KLF15 is an essential negative regulatory factor for the cardiac remodeling response to pressure overload

Cardiology (Switzerland)

Volumn 130, Issue 3, 2015, Pages 143-152

  Yu, Yang ^a   Ma, Jie ^a   Xiao, Yingbin ^a   Yang, Qingjun ^b   Kang, Huali ^a   Zhen, Jie ^b   Yu, Lang ^b   Chen, Lin ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b ZHONGSHAN HOSPITAL OF FUDAN UNIVERSITY   (China)

Author keywords

Adenovirus vector; Cardiac fibroblast; Kr ppel like factor 15; Myocardial fibrosis; Myocardial remodeling; Pressure overload; Transfection

Indexed keywords

COLLAGEN; COLLAGEN TYPE 1; COLLAGEN TYPE 3; CONNECTIVE TISSUE GROWTH FACTOR; KRUPPEL LIKE FACTOR; KRUPPEL LIKE FACTOR 15; MYOCARDIN; MYOCARDIN RELATED TRANSCRIPTION FACTOR A; SHORT HAIRPIN RNA; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; CTGF PROTEIN, RAT; CYTOKINE; KLF15 PROTEIN, RAT; MESSENGER RNA; MYOCARDIN-RELATED TRANSCRIPTION FACTOR-A, RAT; TRANSCRIPTION FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASCENDING AORTA; CARDIOVASCULAR PARAMETERS; CELL STRUCTURE; CONTROLLED STUDY; ECHOCARDIOGRAPHY; GENE EXPRESSION; HEART FUNCTION; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART LEFT VENTRICLE PRESSURE; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE WALL; IN VITRO STUDY; MALE; NONHUMAN; PATHOGENESIS; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRESSURE OVERLOAD; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ANIMAL; CARDIOMEGALY; CELL CULTURE; DISEASE MODEL; FIBROBLAST; FIBROSIS; GENETICS; HEART FAILURE; HEART FUNCTION TEST; HEART MUSCLE; METABOLISM; PATHOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; CARDIOMEGALY; CELLS, CULTURED; COLLAGEN; CONNECTIVE TISSUE GROWTH FACTOR; CYTOKINES; DISEASE MODELS, ANIMAL; ECHOCARDIOGRAPHY; FIBROBLASTS; FIBROSIS; HEART FAILURE; HEART FUNCTION TESTS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; MALE; MYOCARDIUM; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; TRANSCRIPTION FACTORS; TRANSFORMING GROWTH FACTOR BETA;

EID: 84921929873     PISSN: 00086312     EISSN: 14219751     Source Type: Journal    
DOI: 10.1159/000369382     Document Type: Article

References (30)

1. Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Borden WB, et al: Heart disease and stroke statistics-2013 update: a report from the American Heart Association. Circulation 2013; 127:e6-e245.
2. Ruwhof C, van der Laarse A: Mechanical stress-induced cardiac hypertrophy: mechanisms and signal transduction pathways. Car-diovasc Res 2000; 47:23-37.
3. Hill JA, Olson EN: Cardiac plasticity. N Engl J Med 2008; 358:1370-1380.
4. Frey N, Olson EN: Cardiac hypertrophy: the good, the bad, and the ugly. Annu Rev Physi-ol 2003; 65:45-79.
5. Takefuji M, Wirth A, Lukasova M, Takefuji S, Boettger T, Braun T, et al: G(13)-mediated signaling pathway is required for pressure overload-induced cardiac remodeling and heart failure. Circulation 2012; 126:1972-1982.
6. Nishida M, Sato Y, Uemura A, Narita Y, To-zaki-Saitoh H, Nakaya M, et al: P2Y6 recep-tor-Galpha12/13 signalling in cardiomyo-cytes triggers pressure overload-induced cardiac fibrosis. EMBO J 2008; 27:3104-3115.
7. Brown RD, Ambler SK, Mitchell MD, Long CS: The cardiac fibroblast: therapeutic target in myocardial remodeling and failure. Annu Rev Pharmacol Toxicol 2005; 45:657-687.
8. Berk BC, Fujiwara K, Lehoux S: ECM remodeling in hypertensive heart disease. J Clin Invest 2007; 117:568-575.
9. Fisch S, Gray S, Heymans S, Haldar SM, Wang B, Pfister O, et al: Krüppel-like factor 15 is a regulator of cardiomyocyte hypertrophy. Proc Natl Acad Sci USA 2007; 104:7074-7079.
10. Shindo T, Manabe I, Fukushima Y, Tobe K, Aizawa K, Miyamoto S, et al: Krüppel-like zinc-finger transcription factor KLF5/BTEB2 is a target for angiotensin II signaling and an essential regulator of cardiovascular remodeling. Nat Med 2002; 8:856-863.
11. Haldar SM, Lu Y, Jeyaraj D, Kawanami D, Cui Y, Eapen SJ, et al: Klf15 deficiency is a molecular link between heart failure and aortic aneurysm formation. Sci Transl Med 2010; 2: 26ra26.
12. Haldar SM, Ibrahim OA, Jain MK: Krüppel-like factors (KLFs) in muscle biology. J Mol Cell Cardiol 2007; 43:1-10.
13. Doenst T, Goodwin GW, Cedars AM, Wang M, Stepkowski S, Taegtmeyer H: Load-induced changes in vivo alter substrate fluxes and insulin responsiveness of rat heart in vitro. Metabolism 2001; 50:1083-1090.
14. Laskowski A, Woodman OL, Cao AH, Drum-mond GR, Marshall T, Kaye DM, et al: Anti-oxidant actions contribute to the antihyper-trophic effects of atrial natriuretic peptide in neonatal rat cardiomyocytes. Cardiovasc Res 2006; 72:112-123.
15. Xu H, Yi BA, Wu H, Bock C, Gu H, Lui KO, et al: Highly efficient derivation of ventricular cardiomyocytes from induced pluripotent stem cells with a distinct epigenetic signature. Cell Res 2012; 22:142-154.
16. Schram K, Ganguly R, No EK, Fang X, Thong FS, Sweeney G: Regulation of MT1-MMP and MMP-2 by leptin in cardiac fibroblasts involves Rho/ROCK-dependent actin cytoskel-etal reorganization and leads to enhanced cell migration. Endocrinology 2011; 152:2037-2047.
17. Takahashi T, Naito S, Onoda J, Yamauchi A, Nakamura E, Kishino J, et al: Development of a novel immunoassay for the measurement of type II collagen neoepitope generated by col-lagenase cleavage. Clin Chim Acta 2012; 413: 1591-1599.
18. Zhou Z, Liu Y, Miao AD, Wang SQ: Protocat-echuic aldehyde suppresses TNF-alpha-in-duced ICAM-1 and VCAM-1 expression in human umbilical vein endothelial cells. Eur J Pharmacol 2005; 513: 1-8.
19. Zhao ZM, Zhang QY, Dong XL, et al: The expression of myocardial collagen type I and type III mRNA in rat with pressure overload. Sichuan Med J 2009; 30:1859-1861.
20. McConnell BB, Yang VW: Mammalian Krüp-pel-like factors in health and diseases. Physiol Rev 2010; 90:1337-1381.
21. Eghbali M, Czaja MJ, Zeydel M, Weiner FR, Zern MA, Seifter S, et al: Collagen chain mRNAs in isolated heart cells from young and adult rats. J Mol Cell Cardiol 1988; 20:267-276.
22. Xu R, Lin F, Zhang S, Chen X, Hu S, Zheng Z: Signal pathways involved in reverse remodeling of the hypertrophic rat heart after pressure unloading. Int J Cardiol 2010; 143:414-423.
23. Gravning J, Ahmed MS, Qvigstad E, Krobert K, Edvardsen T, Moe IT, et al: Connective tissue growth factor/CCN2 attenuates beta-ad-renergic receptor responsiveness and cardio-toxicity by induction of G protein-coupled receptor kinase-5 in cardiomyocytes. Mol Pharmacol 2013; 84:372-383.
24. Kuwahara K, Kinoshita H, Kuwabara Y, Nak-agawa Y, Usami S, Minami T, et al: Myocar-din-related transcription factor A is a common mediator of mechanical stress-and neu-rohumoral stimulation-induced cardiac hypertrophic signaling leading to activation of brain natriuretic peptide gene expression. Mol Cell Biol 2010; 30:4134-4148.
25. Leenders JJ, Wijnen WJ, van der Made I, Hill-er M, Swinnen M, Vandendriessche T, et al: Repression of cardiac hypertrophy by KLF15: underlying mechanisms and therapeutic implications. PLoS One 2012; 7:e36754.
26. Feinberg MW, Lin Z, Fisch S, Jain MK: An emerging role for Krüppel-like factors in vascular biology. Trends Cardiovasc Med 2004; 14:241-246.
27. Takeda N, Manabe I, Uchino Y, Eguchi K, Matsumoto S, Nishimura S, et al: Cardiac fi-broblasts are essential for the adaptive response of the murine heart to pressure overload. J Clin Invest 2010; 120:254-265.
28. Uchida S, Tanaka Y, Ito H, Saitoh-Ohara F, Inazawa J, Yokoyama KK, et al: Transcrip-tional regulation of the CLC-K1 promoter by myc-associated zinc finger protein and kidney-enriched Krüppel-like factor, a novel zinc finger repressor. Mol Cell Biol 2000; 20:7319-7331.
29. Leenders JJ, Wijnen WJ, Hiller M, van der Made I, Lentink V, van Leeuwen RE, et al: Regulation of cardiac gene expression by KLF15, a repressor of myocardin activity. J Biol Chem 2010; 285:27449-27456.
30. Nagai R, Suzuki T, Aizawa K, Shindo T, Ma-nabe I: Significance of the transcription factor KLF5 in cardiovascular remodeling. J Thromb Haemost 2005; 3:1569-1576.